⌘K

Login Start Free

Home/Insiders/Baumal Caroline

BC

SEC Insider//CIK 0001961100

Baumal Caroline

CIK 00019611001 companyWALTHAM, MA

Transactions

12

Companies

1

Filings

9

CIK

0001961100

Recent Transactions

12 trades

Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-22$21.77/sh−2,797→ 86,527 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-20$19.79/sh−1,882→ 89,324 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-05$25.53/sh−3,020→ 91,206 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-06-09$19.39/sh+82,500→ 82,500 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-21+39,594→ 93,301.37 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-17$29.96/sh−1,853→ 53,707.37 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-06$33.81/sh−2,816→ 55,560.37 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-01-16$66.30/sh+37,000→ 37,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16+25,445→ 58,376.37 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-04$60.05/sh−2,751→ 32,931.37 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-03+35,549→ 35,682.37 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-01-03$50.28/sh+49,000→ 49,000 total

Companies

1

Apellis Pharmaceuticals, Inc.
Chief Medical Officer
$APLS

Recent Filings

9

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451

View on SEC.gov